Immunogenic cell death: Can it be exploited in photodynamic therapy for cancer?

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Panzarini, Elisa ^a   Inguscio, Valentina ^a   Dini, Luciana ^a  

^a UNIVERSITY OF SALENTO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BIM PROTEIN; CALRETICULIN; CASPASE 12; CASPASE 8; CASPASE 9; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B2 PROTEIN; HIGH MOBILITY GROUP B3 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; PROTEIN S 100; PUMA PROTEIN; SPHINGOSINE; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; CYTOKINE; HEAT SHOCK PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOPHAGY; CANCER THERAPY; CELL DEATH; CELL PROLIFERATION; CYTOKINE RELEASE; DENDRITIC CELL; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMAN; IMMUNOGENICITY; IMMUNOSURVEILLANCE; INNATE IMMUNITY; METASTASIS; NEUTROPHIL; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR IMMUNITY; ANIMAL; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; PHOTOCHEMOTHERAPY; TUMOR CELL LINE;

ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; AUTOPHAGY; CALRETICULIN; CELL DEATH; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY;

EID: 84874600820     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/482160     Document Type: Review

References (211)

1. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
2. Blasco M. A., Telomeres and human disease: ageing, cancer and beyond. Nature Reviews Genetics 2005 6 8 611 622 2-s2.0-22944488871 10.1038/nrg1656 (Pubitemid 41044298)
3. Talmadge J. E., Fidler I. J., AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Research 2010 70 14 5649 5669 2-s2.0-77955015464 10.1158/0008-5472.CAN-10-1040
4. Cavallo F., De Giovanni C., Nanni P., Forni G., Lollini P. L., 2011: the immune hallmarks of cancer. Cancer Immunology, Immunotherapy 2011 60 3 319 326 2-s2.0-79953831715 10.1007/s00262-010-0968-0
5. Norell H., Carlsten M., Ohlum T., Malmberg K. J., Masucci G., Schedvins K., Altermann W., Handke D., Atkins D., Seliger B., Kiessling R., Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity. Cancer Research 2006 66 12 6387 6394 2-s2.0-33745714227 10.1158/0008-5472.CAN-06-0029
6. Seliger B., Molecular mechanisms of MHC class I abnormalities and APM components in human tumors. Cancer Immunology, Immunotherapy 2008 57 11 1719 1726 2-s2.0-50649087258 10.1007/s00262-008-0515-4
7. Burnet F. M., The concept of immunological surveillance. Progress in Experimental Tumor Research 1970 13 1 27 2-s2.0-0014887939
8. Dunn G. P., Old L. J., Schreiber R. D., The three Es of cancer immunoediting. Annual Review of Immunology 2004 22 329 360 2-s2.0-2542430341 10.1146/annurev.immunol.22.012703.104803 (Pubitemid 38680426)
9. Chaudhuri D., Suriano R., Mittelman A., Tiwari R. K., Targeting the immune system in cancer. Current Pharmaceutical Biotechnology 2009 10 2 166 184 2-s2.0-65549128316 10.2174/138920109787315114
10. Kepp O., Tesniere A., Schlemmer F., Michaud M., Senovilla L., Zitvogel L., Kroemer G., Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 2009 14 4 364 375 2-s2.0-62449131194 10.1007/s10495-008- 0303-9
11. Zitvogel L., Kepp O., Kroemer G., Decoding cell death signals in inflammation and immunity. Cell 2010 140 6 798 804 2-s2.0-77950366886 10.1016/j.cell.2010.02.015
12. Galluzzi L., Vitale I., Abrams J. M., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., Dawson T. M., Dawson V. L., El-Deiry W. S., Fulda S., Gottlieb E., Green D. R., Hengartner M. O., Kepp O., Knight R. A., Kumar S., Lipton S. A., Lu X., Madeo F., Malorni W., Mehlen P., Nuñez G., Peter M. E., Piacentini M., Rubinsztein D. C., Shi Y., Simon H. U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death and Differentiation 2012 19 1 107 120 2-s2.0-79960237427 10.1038/cdd.2011.96
13. Zitvogel L., Casares N., Péquignot M. O., Chaput N., Albert M. L., Kroemer G., Immune response against dying tumor cells. Advances in Immunology 2004 84 131 179 2-s2.0-3042774310 10.1016/S0065-2776(04)84004-5 (Pubitemid 38887680)
14. Zitvogel L., Kepp O., Senovilla L., Menger L., Chaput N., Kroemer G., Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clinical Cancer Research 2010 16 12 3100 3104 2-s2.0-77953701142 10.1158/1078-0432.CCR-09-2891
15. Garg A. D., Nowis D., Golab J., Agostinis P., Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis 2010 15 9 1050 1071 2-s2.0-77956927110 10.1007/s10495-010-0479-7
16. Agostinis P., Vantieghem A., Merlevede W., de Witte P. A. M., Hypericin in cancer treatment: more light on the way. International Journal of Biochemistry and Cell Biology 2002 34 3 221 241 2-s2.0-0036176587 10.1016/S1357-2725(01)00126-1 (Pubitemid 34159138)
17. Agostinis P., Buytaert E., Breyssens H., Hendrickx N., Regulatory pathways in photodynamic therapy induced apoptosis. Photochemical & Photobiological Sciences 2004 3 8 721 729 2-s2.0-4644258415 10.1039/b315237e (Pubitemid 39302970)
18. Buytaert E., Dewaele M., Agostinis P., Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochimica et Biophysica Acta 2007 1776 1 86 107 2-s2.0-34548247761 10.1016/j.bbcan.2007.07.001 (Pubitemid 47332075)
19. Castano A. P., Demidova T. N., Hamblin M. R., Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis and Photodynamic Therapy 2004 1 4 279 293 2-s2.0-16244383546 10.1016/S1572-1000(05)00007-4 (Pubitemid 40460316)
20. Henderson B. W., Dougherty T. J., How does photodynamic therapy work? Photochemistry and Photobiology 1992 55 1 145 157 2-s2.0-0026494593
21. Brancaleon L., Moseley H., Laser and non-laser light sources for photodynamic therapy. Lasers in Medical Science 2002 17 3 173 186 2-s2.0-0035990884 10.1007/s101030200027
22. Plaetzer K., Krammer B., Berlanda J., Berr F., Kiesslich T., Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers in Medical Science 2009 24 2 259 268 2-s2.0-61349198340 10.1007/s10103-008-0539-1
23. g)] in photosensitized oxidation reactions. Accounts of Chemical Research 2006 39 11 797 804 2-s2.0-33845478539 10.1021/ar050191g
24. Castano A. P., Mroz P., Hamblin M. R., Photodynamic therapy and anti-tumour immunity. Nature Reviews Cancer 2006 6 7 535 545 2-s2.0-33745537921 10.1038/nrc1894 (Pubitemid 43980542)
25. Korbelik M., PDT-associated host response and its role in the therapy outcome. Lasers in Surgery and Medicine 2006 38 5 500 508 2-s2.0-33745685642 10.1002/lsm.20337
26. Mroz P., Yaroslavsky A., Kharkwal G. B., Hamblin M. R., Cell death pathways in photodynamic therapy of cancer. Cancers 2011 3 2 2516 2539 2-s2.0-79959724644 10.3390/cancers3022516
27. Burlacu A., Regulation of apoptosis by Bcl-2 family proteins. Journal of Cellular and Molecular Medicine 2003 7 3 249 257 2-s2.0-0242522206 (Pubitemid 37372044)
28. Oleinick N. L., Morris R. L., Belichenko I., The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochemical & Photobiological Sciences 2002 1 1 1 21 2-s2.0-0036461958 10.1039/b108586g (Pubitemid 37069701)
29. Kessel D., Oleinick N. L., Initiation of autophagy by photodynamic therapy. Methods in Enzymology 2009 453 1 16 2-s2.0-59649099979 10.1016/S0076-6879(08)04001-9
30. Inguscio V., Panzarini E., Dini L., Autophagy contributes to the death/survival balance in cancer photodynamic therapy. Cells 2012 1 464 491
31. Scherz-Shouval R., Elazar Z., ROS, mitochondria and the regulation of autophagy. Trends in Cell Biology 2007 17 9 422 427 2-s2.0-34848920863 10.1016/j.tcb.2007.07.009 (Pubitemid 47499043)
32. Panzarini E., Inguscio V., Dini L., Timing the multiple cell death pathways initiated by Rose Bengal acetate photodynamic therapy. Cell Death and Disease 2011 2 6, article e169 2-s2.0-79959932371 10.1038/cddis.2011.51
33. Panzarini E., Inguscio V., Dini L., Overview of cell death mechanisms induced by Rose Bengal acetate-photodynamic therapy. International Journal of Photoenergy 2011 2011 11 713726 10.1155/2011/713726
34. Gollnick S. O., Vaughan L., Henderson B. W., Generation of effective antitumor vaccines using photodynamic therapy. Cancer Research 2002 62 6 1604 1608 2-s2.0-0037086260 (Pubitemid 34408477)
35. Brackett C. M., Gollnick S. O., Photodynamic therapy enhancement of anti-tumor immunity. Photochemical & Photobiological Sciences 2011 10 5 649 652 2-s2.0-79955551367 10.1039/c0pp00354a
36. Gollnick S. O., Evans S. S., Baumann H., Owczarczak B., Maier P., Vaughan L., Wang W. C., Unger E., Henderson B. W., Role of cytokines in photodynamic therapy-induced local and systemic inflammation. British Journal of Cancer 2003 88 11 1772 1779 2-s2.0-0038265923 10.1038/sj.bjc.6600864 (Pubitemid 36760423)
37. Kousis P. C., Henderson B. W., Maier P. G., Gollnick S. O., Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Research 2007 67 21 10501 10510 2-s2.0-35948959343 10.1158/0008-5472.CAN-07-1778 (Pubitemid 350070826)
38. Preise D., Oren R., Glinert I., Kalchenko V., Jung S., Scherz A., Salomon Y., Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunology, Immunotherapy 2009 58 1 71 84 2-s2.0-54849410264 10.1007/s00262-008-0527-0
39. Jalili A., Makowski M., Świtaj T., Nowis D., Wilczyński G. M., Wilczek E., Chorazy-Massalska M., Radzikowska A., Maśliński W., Białly Ł., Sieńko J., Sieroń A., Adamek M., Basak G., Mróz P., Krasnodbski I. W., Jakóbisiak M., Gołab J., Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clinical Cancer Research 2004 10 13 4498 4508 2-s2.0-3042770952 10.1158/1078-0432.CCR-04-0367 (Pubitemid 38878894)
40. Zitvogel L., Apetoh L., Ghiringhelli F., Kroemer G., Immunological aspects of cancer chemotherapy. Nature Reviews Immunology 2008 8 1 59 73 2-s2.0-37549032137 10.1038/nri2216
41. Green D. R., Ferguson T., Zitvogel L., Kroemer G., Immunogenic and tolerogenic cell death. Nature Reviews Immunology 2009 9 5 353 363 2-s2.0-67349124914 10.1038/nri2545
42. Tesniere A., Apetoh L., Ghiringhelli F., Joza N., Panaretakis T., Kepp O., Schlemmer F., Zitvogel L., Kroemer G., Immunogenic cancer cell death: a key-lock paradigm. Current Opinion in Immunology 2008 20 5 504 511 2-s2.0-50549102898 10.1016/j.coi.2008.05.007
43. Kepp O., Galluzzi L., Martins I., Schlemmer F., Adjemian S., Michaud M., Sukkurwala A. Q., Menger L., Zitvogel L., Kroemer G., Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer and Metastasis Reviews 2011 30 1 61 69 2-s2.0-79952280438 10.1007/s10555-011-9273-4
44. Rubartelli A., Lotze M. T., Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology 2007 28 10 429 436 2-s2.0-34548857335 10.1016/j.it.2007.08.004 (Pubitemid 47444554)
45. Obeid M., Tesniere A., Ghiringhelli F., Fimia G. M., Apetoh L., Perfettini J. L., Castedo M., Mignot G., Panaretakis T., Casares N., Métivier D., Larochette N., Van Endert P., Ciccosanti F., Piacentini M., Zitvogel L., Kroemer G., Calreticulin exposure dictates the immunogenicity of cancer cell death. Nature Medicine 2007 13 1 54 61 2-s2.0-33846057130 10.1038/nm1523 (Pubitemid 46067386)
46. Spisek R., Charalambous A., Mazumder A., Vesole D. H., Jagannath S., Dhodapkar M. V., Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 2007 109 11 4839 4845 2-s2.0-34249650184 10.1182/blood-2006-10-054221 (Pubitemid 46827780)
47. Mukhopadhaya A., Mendecki J., Dong X., Liu L., Kalnicki S., Garg M., Alfieri A., Guha C., Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity. Cancer Research 2007 67 16 7798 7806 2-s2.0-34548012362 10.1158/0008-5472.CAN-07-0203 (Pubitemid 47281374)
48. Didelot C., Lanneau D., Brunet M., Joly A. L., De Thonel A., Chiosis G., Garrido C., Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Current Medicinal Chemistry 2007 14 27 2839 2847 2-s2.0-36749002683 10.2174/092986707782360079 (Pubitemid 350201651)
49. Apetoh L., Ghiringhelli F., Tesniere A., Criollo A., Ortiz C., Lidereau R., Mariette C., Chaput N., Mira J. P., Delaloge S., André F., Tursz T., Kroemer G., Zitvogel L., The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunological Reviews 2007 220 1 47 59 2-s2.0-35748942876 10.1111/j.1600-065X.2007.00573.x (Pubitemid 350045573)
50. Ishii K. J., Suzuki K., Coban C., Takeshita F., Itoh Y., Matoba H., Kohn L. D., Klinman D. M., Genomic DNA released by dying cells induces the maturation of APCs. The Journal of Immunology 2001 167 5 2602 2607 2-s2.0-0035451081 (Pubitemid 32768888)
51. Karikó K., Ni H., Capodici J., Lamphier M., Weissman D., mRNA is an endogenous ligand for toll-like receptor 3. The Journal of Biological Chemistry 2004 279 13 12542 12550 2-s2.0-1842477469 10.1074/jbc.M310175200 (Pubitemid 38445825)
52. Kono H., Chen C. J., Ontiveros F., Rock K. L., Uric acid promotes an acute inflammatory response to sterile cell death in mice. The Journal of Clinical Investigation 2010 120 6 1939 1949 2-s2.0-77953187290 10.1172/JCI40124
53. Foell D., Wittkowski H., Vogl T., Roth J., S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. Journal of Leukocyte Biology 2007 81 1 28 37 2-s2.0-33845868493 10.1189/jlb.0306170 (Pubitemid 46021248)
54. Luheshi N. M., Giles J. A., Lopez-Castejon G., Brough D., Sphingosine regulates the NLRP3-inflammasome and IL-1 β release from macrophages. European The Journal of Immunology 2012 42 3 716 725
55. Srikrishna G., Freeze H. H., Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009 11 7 615 628 2-s2.0-67650482883 10.1593/neo.09284
56. Rock K. L., Kono H., The inflammatory response to cell death. Annual Review of Pathology 2008 3 99 126 2-s2.0-41749104586 10.1146/annurev. pathmechdis.3.121806.151456 (Pubitemid 351488277)
57. Calfee C. S., Matthay M. A., Clinical immunology: culprits with evolutionary ties. Nature 2010 464 7285 41 42 2-s2.0-77950795889 10.1038/464041a
58. Iyer S. S., Pulskens W. P., Sadler J. J., Butter L. M., Teske G. J., Ulland T. K., Eisenbarth S. C., Florquin S., Flavell R. A., Leemans J. C., Sutterwala F. S., Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proceedings of the National Academy of Sciences of the United States of America 2009 106 48 20388 20393 2-s2.0-73949118676 10.1073/pnas.0908698106
59. Schaefer L., Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases. Current Opinion in Pharmacology 2010 10 2 185 190 2-s2.0-77949683133 10.1016/j.coph.2009.11.007
60. Ichim T. E., Zhong Z., Kaushal S., Zheng X., Ren X., Hao X., Joyce J. A., Hanley H. H., Riordan N. H., Koropatnick J., Bogin V., Minev B. R., Min W. P., Tullis R. H., Exosomes as a tumor immune escape mechanism: possible therapeutic implications. Journal of Translational Medicine 2008 6, article 37 2-s2.0-49449105179 10.1186/1479-5876-6-37
61. Zitvogel L., Tesniere A., Kroemer G., Cancer despite immunosurveillance: immunoselection and immunosubversion. Nature Reviews Immunology 2006 6 10 715 727 2-s2.0-33748987908 10.1038/nri1936 (Pubitemid 44453458)
62. Michalak M., Groenendyk J., Szabo E., Gold L. I., Opas M., Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochemical Journal 2009 417 3 651 666 2-s2.0-59849120392 10.1042/BJ20081847
63. 2+ and calcineurin-signaling from the endoplasmic reticulum. Molecules and Cells 2004 17 3 383 389 2-s2.0-4344699902 (Pubitemid 39137095)
64. Gao B., Adhikari R., Howarth M., Nakamura K., Gold M. C., Hill A. B., Knee R., Michalak M., Elliott T., Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity 2002 16 1 99 109 2-s2.0-0036169941 10.1016/S1074-7613(01)00260-6 (Pubitemid 34143220)
65. 2+-dependent nuclear export mediated by calreticulin. Molecular and Cellular Biology 2002 22 17 6286 6297 2-s2.0-0035984194 10.1128/MCB.22.17.6286- 6297.2002 (Pubitemid 34857846)
66. Mesaeli N., Phillipson C., Impaired p53 expression, function, and nuclear localization in calreticullum-deficient cells. Molecular Biology of the Cell 2004 15 4 1862 1870 2-s2.0-1642546248 10.1091/mbc.E03-04-0251 (Pubitemid 38401834)
67. Shaffer K. L., Sharma A., Snapp E. L., Hegde R. S., Regulation of protein compartmentalization expands the diversity of protein function. Developmental Cell 2005 9 4 545 554 2-s2.0-26444571807 10.1016/j.devcel.2005.09.001 (Pubitemid 41430737)
68. Wang W. A., Groenendyk J., Michalak M., Calreticulin signaling in health and disease. The International Journal of Biochemistry & Cell Biology 2012 44 6 842 846
69. Garg A. D., Krysko D. V., Vandenabeele P., Agostinis P., The emergence of phox-ER stress induced immunogenic apoptosis. Oncoimmunology 2012 1 5 786 788
70. Garg A. D., Krysko D. V., Verfaillie T., A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO Journal 2012 31 5 1062 1079
71. Panaretakis T., Kepp O., Brockmeier U., Tesniere A., Bjorklund A. C., Chapman D. C., Durchschlag M., Joza N., Pierron G., Van Endert P., Yuan J., Zitvogel L., Madeo F., Williams D. B., Kroemer G., Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO Journal 2009 28 5 578 590 2-s2.0-62049085194 10.1038/emboj.2009.1
72. Casares N., Pequignot M. O., Tesniere A., Ghiringhelli F., Roux S., Chaput N., Schmitt E., Hamai A., Hervas-Stubbs S., Obeid M., Coutant F., Métivier D., Pichard E., Aucouturier P., Pierron G., Garrido C., Zitvogel L., Kroemer G., Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. The Journal of Experimental Medicine 2005 202 12 1691 1701 2-s2.0-29144530630 10.1084/jem.20050915 (Pubitemid 41815875)
73. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M. C., Ullrich E., Saulnier P., Yang H., Amigorena S., Ryffel B., Barrat F. J., Saftig P., Levi F., Lidereau R., Nogues C., Mira J. P., Chompret A., Joulin V., Clavel-Chapelon F., Bourhis J., André F., Delaloge S., Tursz T., Kroemer G., Zitvogel L., Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine 2007 13 9 1050 1059 2-s2.0-34948820602 10.1038/nm1622 (Pubitemid 47517504)
74. Wemeau M., Kepp O., Tesnière A., Panaretakis T., Flament C., De Botton S., Zitvogel L., Kroemer G., Chaput N., Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia. Cell Death and Disease 2010 1 12, article e104 2-s2.0-79952397249 10.1038/cddis.2010.82
75. Pekáriková A., Sánchez D., Palová- Jelínková L., Calreticulin is a B cell molecular target in some gastrointestinal malignancies. Clinical and Experimental Immunology 2010 160 2 215 222 2-s2.0-77950653586 10.1111/j.1365-2249.2009.04085.x
76. Tan E. M., Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. The Journal of Clinical Investigation 2001 108 10 1411 1415 2-s2.0-0035189977 10.1172/JCI200114451 (Pubitemid 33091976)
77. Zhang J. Y., Casiano C. A., Peng X. X., Koziol J. A., Chan E. K. L., Tan E. M., Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiology Biomarkers & Prevention 2003 12 2 136 143 2-s2.0-12244249834 (Pubitemid 36194003)
78. Bei R., Masuelli L., Palumbo C., Modesti M., Modesti A., A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: inflammation in their induction and impact on tumor growth. Cancer Letters 2009 281 1 8 23 2-s2.0-67349267758 10.1016/j.canlet.2008.11.009
79. Tan T. T., Coussens L. M., Humoral immunity, inflammation and cancer. Current Opinion in Immunology 2007 19 2 209 216 2-s2.0-33847628325 10.1016/j.coi.2007.01.001 (Pubitemid 46356960)
80. Ellyard J. I., Simson L., Parish C. R., Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens 2007 70 1 1 11 2-s2.0-34250020832 10.1111/j.1399-0039.2007.00869.x (Pubitemid 46890289)
81. Gardai S. J., McPhillips K. A., Frasch S. C., Janssen W. J., Starefeldt A., Murphy-Ullrich J. E., Bratton D. L., Oldenborg P. A., Michalak M., Henson P. M., Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005 123 2 321 334 2-s2.0-26844468253 10.1016/j.cell.2005.08.032 (Pubitemid 41457220)
82. Vandivier R. W., Ogden C. A., Fadok V. A., Hoffmann P. R., Brown K. K., Botto M., Walport M. J., Fisher J. H., Henson P. M., Greene K. E., Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. The Journal of Immunology 2002 169 7 3978 3986 2-s2.0-0036785571
83. Orr A. W., Elzie C. A., Kucik D. F., Murphy-Ullrich J. E., Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. Journal of Cell Science 2003 116 14 2917 2927 2-s2.0-0042170209 10.1242/jcs.00600 (Pubitemid 36926981)
84. Ogden C. A., DeCathelineau A., Hoffmann P. R., Bratton D., Fadok B., Ghebrehiwet V. A., Henson P. M., C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. The Journal of Experimental Medicine 2001 194 6 781 795 2-s2.0-0035903289 10.1084/jem.194.6.781 (Pubitemid 32983014)
85. Honoré C., Hummelshoj T., Hansen B. E., Madsen H. O., Eggleton P., Garred P., The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis & Rheumatism 2007 56 5 1598 1607 2-s2.0-34248592214 10.1002/art.22564 (Pubitemid 46764089)
86. Jensen M. L., Honoré C., Hummelshøj T., Hansen B. E., Madsen H. O., Garred P., Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Molecular Immunology 2007 44 5 856 865 2-s2.0-33748759816 10.1016/j.molimm.2006.04.002 (Pubitemid 44415007)
87. Berwin B., Hart J. P., Rice S., Gass C., Pizzo S. V., Post S. R., Nicchitta C. V., Scavenger receptor-a mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO Journal 2003 22 22 6127 6136 2-s2.0-0345305789 10.1093/emboj/cdg572 (Pubitemid 37463255)
88. Berwin B., Delneste Y., Lovingood R. V., Post S. R., Pizzo S. V., SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin. The Journal of Biological Chemistry 2004 279 49 51250 51257 2-s2.0-10944228434 10.1074/jbc.M406202200 (Pubitemid 40017869)
89. Basu S., Binder R. J., Ramalingam T., Srivastava P. K., CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001 14 3 303 313 2-s2.0-0035070198 10.1016/S1074-7613(01)00111-X (Pubitemid 32289294)
90. Papp S., Opas M., Eggleton P., Michalak M., Sub-cellular distribution of calreticulina. Calreticulin 2003 2nd Berlin, Germany Springer 38 48. Molecular Biology Intelligence Unit
91. Zeng G., Aldridge M. E., Tian X., Seiler D., Zhang X., Jin Y., Rao J., Li W., Chen D., Langford M. P., Duggan C., Belldegrun A. S., Dubinett S. M., Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system. The Journal of Immunology 2006 177 6 3582 3589 2-s2.0-33748489532 (Pubitemid 44359889)
92. Arosa F. A., de Jesus O., Porto G., Carmo A. M., De Sousa M., Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules. The Journal of Biological Chemistry 1999 274 24 16917 16922 2-s2.0-0033546416 10.1074/jbc.274.24.16917 (Pubitemid 29275144)
93. Lanneau D., Brunet M., Frisan E., Solary E., Fontenay M., Garrido C., Heat shock proteins: essential proteins for apoptosis regulation: apoptosis review series. Journal of Cellular and Molecular Medicine 2008 12 3 743 761 2-s2.0-44149104599 10.1111/j.1582-4934.2008.00273.x (Pubitemid 351718062)
94. Tesniere A., Panaretakis T., Kepp O., Apetoh L., Ghiringhelli F., Zitvogel L., Kroemer G., Molecular characteristics of immunogenic cancer cell death. Cell Death and Differentiation 2008 15 1 3 12 2-s2.0-37349051718 10.1038/sj.cdd.4402269 (Pubitemid 350286167)
95. Beere H. M., Wolf B. B., Cain K., Mosser D. D., Mahboubi A., Kuwana T., Tailor P., Morimoto R. I., Cohen G. M., Green D. R., Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nature Cell Biology 2000 2 8 469 475 2-s2.0-0034253533 10.1038/35019501
96. Ravagnan L., Gurbuxani S., Susin S. A., Maisse C., Daugas E., Zamzami N., Mak T., Jäättelä M., Penninger J. M., Garrido C., Kroemer G., Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nature Cell Biology 2001 3 9 839 843 2-s2.0-17944366977 10.1038/ncb0901-839 (Pubitemid 32842690)
97. Wadhwa R., Yaguchi T., Hasan M. K., Mitsui Y., Reddel R. R., Kaul S. C., Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Experimental Cell Research 2002 274 2 246 253 2-s2.0-0036346345 10.1006/excr.2002.5468
98. Lee J. S., Lee J. J., Seo J. S., HSP70 deficiency results in activation of c-Jun N-terminal kinase, extracellular signal-regulated kinase, and caspase-3 in hyperosmolarity-induced apoptosis. The Journal of Biological Chemistry 2005 280 8 6634 6641 2-s2.0-14844307612 10.1074/jbc.M412393200 (Pubitemid 40341215)
99. Stankiewicz A. R., Lachapelle G., Foo C. P. Z., Radicioni S. M., Mosser D. D., Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. The Journal of Biological Chemistry 2005 280 46 38729 38739 2-s2.0-33244474580 10.1074/jbc.M509497200 (Pubitemid 43853776)
100. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S. M., Kumar V., Weichselbaum R., Nalin C., Alnemri E. S., Kufe D., Kharbanda S., Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO Journal 2000 19 16 4310 4322 2-s2.0-0034664030 (Pubitemid 30623742)
101. Ozes O. N., Mayo L. D., Gustin J. A., Pfeffer S. R., Pfeffer L. M., Donner D. B., NF- B activation by tumour necrosis factor requires tie Akt serine- threonine kinase. Nature 1999 401 6748 82 85 2-s2.0-0033517189 10.1038/43466 (Pubitemid 29418447)
102. Shi H., Cao T., Connolly J. E., Monnet L., Bennett L., Chapel S., Bagnis C., Mannoni P., Davoust J., Palucka A. K., Banchereau J., Hyperthermia enhances CTL cross-priming. The Journal of Immunology 2006 176 4 2134 2141 2-s2.0-32044456037 (Pubitemid 43201660)
103. Massé D., Ebstein F., Bougras G., Harb J., Meflah K., Grégoire M., Increased expression of inducible HSP70 in apoptotic cells is correlated with their efficacy for antitumor vaccine therapy. International Journal of Cancer 2004 111 4 575 583 2-s2.0-3843132104 10.1002/ijc.20249 (Pubitemid 39045325)
104. Arispe N., Doh M., Simakova O., Kurganov B., De Maio A., Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability. FASEB Journal 2004 18 14 1636 1645 2-s2.0-7744222195 10.1096/fj.04-2088com (Pubitemid 39463703)
105. Bartunkov J., Spisek R., Krysko D. V., Vandenabeele P., Impact of tumour cell death on the activation of anti-tumour immune response. Phagocytosis of Dying Cells, Science+Business Media B.V. 2009 Berlin, Germany Springer Science, Business Media 347 370
106. Spisek R., Dhodapkar M. V., Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells. Cell Cycle 2007 6 16 1962 1965 2-s2.0-34548271716 (Pubitemid 47327881)
107. Doody A. D. H., Kovalchin J. T., Mihalyo M. A., Hagymasi A. T., Drake C. G., Adler A. J., Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. The Journal of Immunology 2004 172 10 6087 6092 2-s2.0-2442517310 (Pubitemid 38621211)
108. Binder R. J., Blachere N. E., Srivastava P. K., Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. The Journal of Biological Chemistry 2001 276 20 17163 17171 2-s2.0-0035907379 10.1074/jbc.M011547200
109. Asea A., Rehli M., Kabingu E., Boch J. A., Baré O., Auron P. E., Stevenson M. A., Calderwood S. K., Novel signal transduction pathway utilized by extracellular HSP70. Role of toll-like receptor (TLR) 2 and TLR4. The Journal of Biological Chemistry 2002 277 17 15028 15034 2-s2.0-0037177825 10.1074/jbc.M200497200 (Pubitemid 34952579)
110. Asea A., Kraeft S. K., Kurt-Jones E. A., Stevenson M. A., Chen L. B., Finberg R. W., Koo G. C., Calderwood S. K., HSP70 stimulates cytokine production through a CD 14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nature Medicine 2000 6 4 435 442 2-s2.0-0034113617 10.1038/74697 (Pubitemid 30208161)
111. Wang Y., Kelly C. G., Singh M., McGowan E. G., Carrara A. S., Bergmeier L. A., Lehner T., Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. The Journal of Immunology 2002 169 5 2422 2429 2-s2.0-0036721692 (Pubitemid 34920985)
112. Lehner T., Wang Y., Whittall T., McGowan E., Kelly C. G., Singh M., Functional domains of HSP70 stimulate generation of cytokines and chemokines, maturation of dendritic and adjuvanticity. Biochemical Society Transactions 2004 32 4 629 632 2-s2.0-4344582355 10.1042/BST0320629 (Pubitemid 39120401)
113. Singh-Jasuja H., Toes R. E. M., Spee P., Münz C., Hilf N., Schoenberger S. P., Ricciardi-Castagnoli P., Neefjes J., Rammensee H. G., Arnold-Schild D., Schild H., Cross-presentation of glycoprotein 96-associated antigens: on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. The Journal of Experimental Medicine 2000 191 11 1965 1974 2-s2.0-0034608387 10.1084/jem.191.11.1965 (Pubitemid 30390358)
114. Hickman-Miller H. D., Hildebrand W. H., The immune response under stress: the role of HSP-derived peptides. Trends in Immunology 2004 25 8 427 433 2-s2.0-3242710441 10.1016/j.it.2004.05.011 (Pubitemid 38951084)
115. Multhoff G., Mizzen L., Winchester C. C., Milner C. M., Wenk S., Eissner G., Kampinga H. H., Laumbacher B., Johnson J., Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells. Experimental Hematology 1999 27 11 1627 1636 2-s2.0-0032727033 10.1016/S0301-472X(99)00104-6 (Pubitemid 29526747)
116. Feng H., Zeng Y., Graner M. W., Likhacheva A., Katsanis E., Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood 2003 101 1 245 252 2-s2.0-0037222686 10.1182/blood-2002-05-1580 (Pubitemid 36025914)
117. Barreto A., Gonzalez J. M., Kabingu E., Asea A., Fiorentino S., Stress-induced release of HSC70 from human tumors. Cellular Immunology 2003 222 2 97 104 2-s2.0-0037783960 10.1016/S0008-8749(03)00115-1 (Pubitemid 36765431)
118. Yang C., Robbins P. D., The roles of tumour-derived exosomes in cancer pathogenesis. Clinical and Developmental Immunology 2011 2011 11 842849 10.1155/2011/842849
119. Gastpar R., Gehrmann M., Bausero M. A., Asea A., Gross C., Schroeder J. A., Multhoff G., Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Research 2005 65 12 5238 5247 2-s2.0-20444431560 10.1158/0008-5472.CAN-04-3804 (Pubitemid 40827334)
120. Bausero M. A., Gastpar R., Multhoff G., Asea A., Alternative mechanism by which IFN- γ enhances tumor recognition: active release of heat shock protein 72. The Journal of Immunology 2005 175 5 2900 2912 2-s2.0-23844544016 (Pubitemid 41170507)
121. Lancaster G. I., Febbraio M. A., Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. The Journal of Biological Chemistry 2005 280 24 23349 23355 2-s2.0-20744436655 10.1074/jbc.M502017200 (Pubitemid 40853248)
122. van Eden W., Spiering R., Broere F., van der Zee R., A case of mistaken identity: HSPs are no DAMPs but DAMPERs. Cell Stress and Chaperones 2012 17 3 281 292
123. Kono H., Rock K. L., How dying cells alert the immune system to danger. Nature Reviews Immunology 2008 8 4 279 289 2-s2.0-41149118513 10.1038/nri2215 (Pubitemid 351432799)
124. Chen G. Y., Nuñez G., Sterile inflammation: sensing and reacting to damage. Nature Reviews Immunology 2010 10 12 826 837 2-s2.0-78649526394 10.1038/nri2873
125. Wallin R. P. A., Lundqvist A., Moré S. H., von Bonin A., Kiessling R., Ljunggren H. G., Heat-shock proteins as activators of the innate immune system. Trends in Immunology 2002 23 3 130 135 2-s2.0-0036499004 10.1016/S1471-4906(01)02168-8 (Pubitemid 34178294)
126. Bendz H., Marincek B. C., Momburg F., Ellwart J. W., Issels R. D., Nelson P. J., Noessner E., Calcium signaling in dendritic cells by human or mycobacterial Hsp70 is caused by contamination and is not required for Hsp70-mediated enhancement of cross-presentation. The Journal of Biological Chemistry 2008 283 39 26477 26483 2-s2.0-55549122352 10.1074/jbc.M803310200
127. Motta A., Schmitz C., Rodrigues L., Ribeiro F., Teixeira C., Detanico T., Bonan C., Zwickey H., Bonorino C., Mycobacterium tuberculosis heat-shock protein 70 impairs maturation of dendritic cells from bone marrow precursors, induces interleukin-10 production and inhibits T-cell proliferation in vitro. Immunology 2007 121 4 462 472 2-s2.0-34447109876 10.1111/j.1365-2567.2007.02564. x (Pubitemid 47030084)
128. Dhodapkar M. V., Dhodapkar K. M., Li Z., Role of chaperones and Fc γ R in immunogenic death. Current Opinion in Immunology 2008 20 5 512 517 2-s2.0-50549099059 10.1016/j.coi.2008.05.002
129. Wang H., Bloom O., Zhang M., Vishnubhakat J. M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K. R., Faist E., Abraham E., Andersson J., Andersson U., Molina P. E., Abumrad N. N., Sama A., Tracey K. J., HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999 285 5425 248 251 2-s2.0-0033538467 10.1126/science.285.5425.248 (Pubitemid 29329996)
130. Kazama H., Ricci J. E., Herndon J. M., Hoppe G., Green D. R., Ferguson T. A., Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008 29 1 21 32 2-s2.0-46749136790 10.1016/j.immuni.2008.05.013 (Pubitemid 351952462)
131. Guazzi S., Strangio A., Franzi A. T., Bianchi M. E., HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expression Patterns 2003 3 1 29 33 2-s2.0-0037344044 10.1016/S1567-133X(02) 00093-5 (Pubitemid 36356037)
132. Vaccari T., Beltrame M., Ferrari S., Bianchi M. E., Hmg4, a new member of the Hmg1/2 gene family. Genomics 1998 49 2 247 252 2-s2.0-0032522232 10.1006/geno.1998.5214 (Pubitemid 28240691)
133. Ronfani L., Ferraguti M., Croci L., Ovitt C. E., Schöler H. R., Consalez G. G., Bianchi M. E., Reduced fertility and spermatogenesis defects in mice lacking chromosomal protein Hmgb2. Development 2001 128 8 1265 1273 2-s2.0-0035036205 (Pubitemid 32409649)
134. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., Cossu G., Bianchi M. E., Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. Journal of Cell Biology 2004 164 3 441 449 2-s2.0-0842266582 10.1083/jcb.200304135 (Pubitemid 38174771)
135. Park J. S., Svetkauskaite D., He Q., Kim J. Y., Strassheim D., Ishizaka A., Abraham E., Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. The Journal of Biological Chemistry 2004 279 9 7370 7377 2-s2.0-1542380035 10.1074/jbc.M306793200 (Pubitemid 38294612)
136. Yang D., Chen Q., Yang H., Tracey K. J., Bustin M., Oppenheim J. J., High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. Journal of Leukocyte Biology 2007 81 1 59 66 2-s2.0-33845885124 10.1189/jlb.0306180 (Pubitemid 46021253)
137. Orlova V. V., Choi E. Y., Xie C., Chavakis E., Bierhaus A., Ihanus E., Ballantyne C. M., Gahmberg C. G., Bianchi M. E., Nawroth P. P., Chavakis T., A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO Journal 2007 26 4 1129 1139 2-s2.0-33847193122 10.1038/sj.emboj.7601552
138. Tang D., Kang R., Zeh H. J. III, Lotze M. T., High-mobility group box 1 and cancer. Biochimica et Biophysica Acta 2010 1799 1-2 131 140 2-s2.0-74549175673 10.1016/j.bbagrm.2009.11.014
139. Scaffidi P., Misteli T., Bianchi M. E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002 418 6894 191 195 2-s2.0-0037062934 10.1038/nature00858 (Pubitemid 34773774)
140. Thorburn J., Horita H., Redzic J., Hansen K., Frankel A. E., Thorburn A., Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death and Differentiation 2009 16 1 175 183 2-s2.0-57649217868 10.1038/cdd.2008.143
141. Choi J. J., Reich C. F. III, Pisetsky D. S., Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro. Scandinavian The Journal of Immunology 2004 60 1-2 159 166 2-s2.0-3242706096 10.1111/j.0300-9475.2004.01470. x (Pubitemid 38943063)
142. Bell C. W., Jiang W., Reich C. F. III, Pisetsky D. S., The extracellular release of HMGB1 during apoptotic cell death. American Journal of Physiology 2006 291 6 C1318 C1325 2-s2.0-33845333359 10.1152/ajpcell.00616.2005 (Pubitemid 44878603)
143. Tian J., Avalos A. M., Mao S. Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L. L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M. K., Fitzgerald K. A., Latz E., Kiener P. A., Coyle A. J., Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nature Immunology 2007 8 5 487 496 2-s2.0-34247236200 10.1038/ni1457 (Pubitemid 46605917)
144. Liu L., Yang M., Kang R., Wang Z., Zhao Y., Yu Y., Xie M., Yin X., Livesey K. M., Lotze M. T., Tang D., Cao L., DAMP-mediated autophagy contributes to drug resistance. Autophagy 2011 7 1 112 114 2-s2.0-78650831662 10.4161/auto.7.1.14005
145. Liu L., Yang M., Kang R., Wang Z., Zhao Y., Yu Y., Xie M., Yin X., Livesey K. M., Lotze M. T., Tang D., Cao L., HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 2011 25 1 23 31 2-s2.0-78651286142 10.1038/leu.2010.225
146. Tang D., Kang R., Cheh C. W., Livesey K. M., Liang X., Schapiro N. E., Benschop R., Sparvero L. J., Amoscato A. A., Tracey K. J., Zeh H. J., Lotze M. T., HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010 29 38 5299 5310 2-s2.0-77957106729 10.1038/onc.2010.261
147. Krysko D. V., Leybaert L., Vandenabeele P., D'Herde K., Gap junctions and the propagation of cell survival and cell death signals. Apoptosis 2005 10 3 459 469 2-s2.0-21244446261 10.1007/s10495-005-1875-2 (Pubitemid 40896652)
148. Decrock E., Vinken M., De Vuyst E., Krysko D. V., D'Herde K., Vanhaecke T., Vandenabeele P., Rogiers V., Leybaert L., Connexin-related signaling in cell death: to live or let die? Cell Death and Differentiation 2009 16 4 524 536 2-s2.0-62849117060 10.1038/cdd.2008.196
149. Shi Y., Zheng W., Rock K. L., Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14590 14595 2-s2.0-0034687696 10.1073/pnas.260497597 (Pubitemid 32016620)
150. Shi Y., Rock K. L., Cell death releases endogenous adjuvants that selectively enhance immune surveillance of particulate antigens. European The Journal of Immunology 2002 32 1 155 162 (Pubitemid 34092833)
151. Ferrari D., Wesselborg S., Bauer M. K. A., Schulze-Osthoff K., Extracellular ATP activates transcription factor NF- B through the P2Z purinoreceptor by selectively targeting NF- B p65 (RelA). The Journal of Cell Biology 1997 139 7 1635 1643 2-s2.0-0031425953 10.1083/jcb.139.7.1635 (Pubitemid 28079229)
152. Stout C. E., Costantin J. L., Naus C. C. G., Charles A. C., Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. The Journal of Biological Chemistry 2002 277 12 10482 10488 2-s2.0-0037155841 10.1074/jbc.M109902200 (Pubitemid 34968170)
153. Zhang Z., Chen G., Zhou W., Song A., Xu T., Luo Q., Wang W., Gu X. S., Duan S., Regulated ATP release from astrocytes through lysosome exocytosis. Nature Cell Biology 2007 9 8 945 953 2-s2.0-34547562467 10.1038/ncb1620 (Pubitemid 47190449)
154. Eigenbrod T., Park J. H., Harder J., Iwakura Y., Núñez G., Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 α released from dying cells. The Journal of Immunology 2008 181 12 8194 8198 2-s2.0-58849151813
155. Vanden Berghe T., Kalai M., Denecker G., Meeus A., Saelens X., Vandenabeele P., Necrosis is associated with IL-6 production but apoptosis is not. Cellular Signalling 2006 18 3 328 335 2-s2.0-27844605402 10.1016/j.cellsig.2005.05.003 (Pubitemid 41661348)
156. Bottazzi B., Garlanda C., Salvatori G., Jeannin P., Manfredi A., Mantovani A., Pentraxins as a key component of innate immunity. Current Opinion in Immunology 2006 18 1 10 15 2-s2.0-30044448336 10.1016/j.coi.2005.11.009 (Pubitemid 43049642)
157. Oldenborg P. A., Gresham H. D., Lindberg F. P., CD47-signal regulatory protein α (SIRP α) regulates Fc γ and complement receptor-mediated phagocytosis. The Journal of Experimental Medicine 2001 193 7 855 862 2-s2.0-0035794312 10.1084/jem.193.7.855 (Pubitemid 32524535)
158. Castelli C., Ciupitu A. T., Rini F., Rivoltini L., Mazzocchi A., Kiessling R., Parmiani G., Human heat shock protein 70 peptide complexes specifically activate antimelanoma t cells. Cancer Research 2001 61 1 222 227 2-s2.0-0035132104 (Pubitemid 32095721)
159. Delamarre L., Couture R., Mellman I., Trombetta E. S., Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. The Journal of Experimental Medicine 2006 203 9 2049 2055 2-s2.0-33748475526 10.1084/jem.20052442 (Pubitemid 44352226)
160. Shiratsuchi A., Watanabe I., Takeuchi O., Akira S., Nakanishi Y., Inhibitory effect of Toll-like receptor 4 on fusion between phagosomes and endosomes/lysosomes in macrophages. The Journal of Immunology 2004 172 4 2039 2047 2-s2.0-0842300367 (Pubitemid 38182349)
161. Ghiringhelli F., Apetoh L., Tesniere A., Aymeric L., Ma Y., Ortiz C., Vermaelen K., Panaretakis T., Mignot G., Ullrich E., Perfettini J. L., Schlemmer F., Tasdemir E., Uhl M., Génin P., Civas A., Ryffel B., Kanellopoulos J., Tschopp J., André F., Lidereau R., McLaughlin N. M., Haynes N. M., Smyth M. J., Kroemer G., Zitvogel L., Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nature Medicine 2009 15 10 1170 1178 2-s2.0-70350569295 10.1038/nm.2028
162. Latz E., The inflammasomes: mechanisms of activation and function. Current Opinion in Immunology 2010 22 1 28 33 2-s2.0-77249118801 10.1016/j.coi.2009.12.004
163. Franchi L., Eigenbrod T., Muñoz-Planillo R., Nuñez G., The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nature Immunology 2009 10 3 241 247 2-s2.0-60749104683 10.1038/ni.1703
164. Elliott M. R., Chekeni F. B., Trampont P. C., Lazarowski E. R., Kadl A., Walk S. F., Park D., Woodson R. I., Ostankovich M., Sharma P., Lysiak J. J., Harden T. K., Leitinger N., Ravichandran K. S., Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009 461 7261 282 286 2-s2.0-70249090374 10.1038/nature08296
165. Pizova K., Tomankova K., Daskova A., Binder S., Bajgar R., Kolarova H., Photodynamic therapy for enhancing antitumour immunity. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic 2012 156 2 93 102 10.5507/bp.2012.056
166. Zitvogel L., Apetoh L., Ghiringhelli F., André F., Tesniere A., Kroemer G., The anticancer immune response: indispensable for therapeutic success? The Journal of Clinical Investigation 2008 118 6 1991 2001 2-s2.0-45749134564 10.1172/JCI35180 (Pubitemid 351872317)
167. Garg A. D., Krysko D. V., Vandenabeele P., Agostinis P., DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown. Photochemical & Photobiological Sciences 2011 10 5 670 680 2-s2.0-79955562268 10.1039/c0pp00294a
168. Olivo M., Bhuvaneswari R., Lucky S. S., Dendukuri N., Soo-Ping Thong P., Targeted therapy of cancer using photodynamic therapy in combination with multi-faceted anti-tumor modalities. Pharmaceuticals 2010 3 5 1507 529 2-s2.0-77954900191 10.3390/ph3051507
169. Gollnick S. O., Brackett C. M., Enhancement of anti-tumor immunity by photodynamic therapy. Immunologic Research 2010 46 1-3 216 226 2-s2.0-77949423008 10.1007/s12026-009-8119-4
170. DeNardo D. G., Andreu P., Coussens L. M., Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity. Cancer and Metastasis Reviews 2010 29 2 309 316 2-s2.0-77954563614 10.1007/s10555-010- 9223-6
171. Grivennikov S. I., Greten F. R., Karin M., Immunity, inflammation, and cancer. Cell 2010 140 6 883 899 2-s2.0-77950346282 10.1016/j.cell.2010.01.025
172. Karnoub A. E., Weinberg R. A., Chemokine networks and breast cancer metastasis. Breast Disease 2006 26 1 75 85 2-s2.0-34247468926 (Pubitemid 46647416)
173. Qian B. Z., Pollard J. W., Macrophage diversity enhances tumor progression and metastasis. Cell 2010 141 1 39 51 2-s2.0-77950950894 10.1016/j.cell.2010.03.014
174. Ryter S. W., Gomer C. J., Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochemistry and Photobiology 1993 58 5 753 756 2-s2.0-0027688564
175. Legrand-Poels S., Bours V., Piret B., Pflaum M., Epe B., Rentier B., Piette J., Transcription factor NF- B is activated by photosensitization generating oxidative DNA damages. The Journal of Biological Chemistry 1995 270 12 6925 6934 2-s2.0-0028986722 10.1074/jbc.270.12.6925
176. Matroule J. Y., Bonizzi G., Morlière P., Paillous N., Santus R., Bours V., Piette J., Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF- B through the interleukin-1 receptor-dependent signaling pathway. The Journal of Biological Chemistry 1999 274 5 2988 3000 2-s2.0-0033614029 10.1074/jbc.274.5.2988 (Pubitemid 29075386)
177. Granville D. J., Carthy C. M., Jiang H., Levy J. G., McManus B. M., Matroule J. Y., Piette J., Hunt D. W. C., Nuclear factor- B activation by the photochemotherapeutic agent verteporfin. Blood 2000 95 1 256 262 2-s2.0-0033628631 (Pubitemid 30017250)
178. Kick G., Messer G., Goetz A., Plewig G., Kind P., Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF- B DNA binding. Cancer Research 1995 55 11 2373 2379 2-s2.0-0029059994
179. Gollnick S. O., Lee B. Y., Vaughan L., Owczarczak B., Henderson B. W., Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes. Photochemistry and Photobiology 2001 73 2 170 177
180. Firczuk M., Nowis D., Gołb J., PDT-induced inflammatory and host responses. Photochemical & Photobiological Sciences 2011 10 5 653 663 2-s2.0-79955558065 10.1039/c0pp00308e
181. Cecic I., Korbelik M., Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Letters 2002 183 1 43 51 2-s2.0-0037044115 10.1016/S0304-3835(02)00092-7 (Pubitemid 34607350)
182. Cecic I., Parkins C. S., Korbelik M., Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors. Photochemistry and Photobiology 2001 74 5 712 720
183. Krosl G., Korbelik M., Dougherty G. J., Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. British Journal of Cancer 1995 71 3 549 555 2-s2.0-0028957555
184. de Bruijn H. S., Sluiter W., van der Ploeg-van den Heuvel A., Sterenborg H. J. C. M., Robinson D. J., Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy. Photodermatology Photoimmunology and Photomedicine 2006 22 5 238 246 2-s2.0-33748261445 10.1111/j.1600-0781.2006.00240.x (Pubitemid 44317157)
185. Korbelik M., Sun J., Cecic I., Serrano K., Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochemical & Photobiological Sciences 2004 3 8 812 816 2-s2.0-4644286775 10.1039/b315663j (Pubitemid 39302983)
186. Cecic I., Serrano K., Gyongyossy-Issa M., Korbelik M., Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy. Cancer Letters 2005 225 2 215 223 2-s2.0-20644459468 10.1016/j.canlet.2004.11.059 (Pubitemid 40835869)
187. Korbelik M., Cecic I., Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy. Journal of Photochemistry and Photobiology B 2008 93 1 53 59 2-s2.0-52749086843 10.1016/j.jphotobiol.2008.04.005
188. Cecic I., Korbelik M., Deposition of complement proteins on cells treated by photodynamic therapy in vitro. Journal of Environmental Pathology, Toxicology and Oncology 2006 25 1-2 189 203 2-s2.0-33644768293 (Pubitemid 43341240)
189. Cecic I., Sun J., Korbelik M., Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells. Photochemistry and Photobiology 2006 82 2 558 562 2-s2.0-33646269285 10.1562/2005-09-09-RA-681
190. Stott B., Korbelik M., Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy. Cancer Immunology, Immunotherapy 2007 56 5 649 658 2-s2.0-33847418810 10.1007/s00262-006-0221-z (Pubitemid 46348734)
191. Dunkelberger J. R., Song W. C., Complement and its role in innate and adaptive immune responses. Cell Research 2010 20 1 34 50 2-s2.0-73849090193 10.1038/cr.2009.139
192. Kabingu E., Vaughan L., Owczarczak B., Ramsey K. D., Gollnick S. O., CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. British Journal of Cancer 2007 96 12 1839 1848 2-s2.0-34250376737 10.1038/sj.bjc.6603792 (Pubitemid 46912014)
193. Thong P. S. P., Ong K. W., Goh N. S. G., Kho K. W., Manivasager V., Bhuvaneswari R., Olivo M., Soo K. C., Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. The Lancet Oncology 2007 8 10 950 952 2-s2.0-34748907209 10.1016/S1470-2045(07)70318-2 (Pubitemid 47488070)
194. Kabingu E., Oseroff A. R., Wilding G. E., Gollnick S. O., Enhanced systemic immune reactivity to a basal cell carcinoma associated antigen following photodynamic therapy. Clinical Cancer Research 2009 15 13 4460 4466 2-s2.0-67650364257 10.1158/1078-0432.CCR-09-0400
195. Mroz P., Szokalska A., Wu M. X., Hamblin M. R., Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS ONE 2010 5 12 2-s2.0-78650770665 10.1371/journal.pone.0015194 e15194
196. Gollnick S. O., Musser D. A., Oseroff A. R., Vaughan L., Owczarczak B., Henderson B. W., IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response. Photochemistry and Photobiology 2001 74 6 811 816
197. Yusuf N., Katiyar S. K., Elmets C. A., The immunosuppressive effects of phthalocyanine photodynamic therapy in mice are mediated by CD4+ and CD8+ T cells and can be adoptively transferred to naive recipients. Photochemistry and Photobiology 2008 84 2 366 370 2-s2.0-41049113310 10.1111/j.1751-1097.2007. 00270.x (Pubitemid 351421387)
198. Bluestone J. A., Tang Q., How do CD4+CD25+ regulatory T cells control autoimmunity? Current Opinion in Immunology 2005 17 6 638 642 2-s2.0-27144495833 10.1016/j.coi.2005.09.002 (Pubitemid 41506909)
199. Marie J. C., Letterio J. J., Gavin M., Rudensky A. Y., TGF- β 1 maintains suppressor function and Foxp3 expression in CD4 +CD25+ regulatory T cells. The Journal of Experimental Medicine 2005 201 7 1061 1067 2-s2.0-17144400393 10.1084/jem.20042276 (Pubitemid 40524674)
200. Ghiringhelli F., Puig P. E., Roux S., Parcellier A., Schmitt E., Solary E., Kroemer G., Martin F., Chauffert B., Zitvogel L., Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. The Journal of Experimental Medicine 2005 202 7 919 929 2-s2.0-25844504654 10.1084/jem.20050463 (Pubitemid 41396892)
201. Veldhoen M., Moncrieffe H., Hocking R. J., Atkins C. J., Stockinger B., Modulation of dendritic cell function by naive and regulatory CD4+ T cells. The Journal of Immunology 2006 176 10 6202 6210 2-s2.0-33646487145
202. Castano A. P., Mroz P., Wu M. X., Hamblin M. R., Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proceedings of the National Academy of Sciences of the United States of America 2008 105 14 5495 5500 2-s2.0-44449104069 10.1073/pnas.0709256105 (Pubitemid 351753891)
203. Korbelik M., Sun J., Cecic I., Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Research 2005 65 3 1018 1026 2-s2.0-13444271569 (Pubitemid 40216464)
204. Garg A. D., Nowis D., Golab J., Vandenabeele P., Krysko D. V., Agostinis P., Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochimica et Biophysica Acta 2010 1805 1 53 71 2-s2.0-75349083568 10.1016/j.bbcan.2009.08.003
205. Korbelik M., Zhang W., Merchant S., Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release. Cancer Immunology, Immunotherapy 2011 60 10 1431 1437 2-s2.0-79957803394 10.1007/s00262-011-1047-x
206. Zhou F., Xing D., Chen W. R., Regulation of HSP70 on activating macrophages using PDT-induced apoptotic cells. International Journal of Cancer 2009 125 6 1380 1389 2-s2.0-68249159490 10.1002/ijc.24520
207. Mitra S., Giesselman B. R., De Jesús-Andino F. J., Foster T. H., Tumor response to mTHPC-mediated photodynamic therapy exhibits strong correlation with extracellular release of HSP70. Lasers in Surgery and Medicine 2011 43 7 632 643
208. Etminan N., Peters C., Lakbir D., Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitro. British Journal of Cancer 2011 105 7 961 969
209. Korbelik M., Sun J., Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunology, Immunotherapy 2006 55 8 900 909 2-s2.0-33646376719 10.1007/s00262-005-0088-4 (Pubitemid 43673579)
210. Garg A. D., Krysko D. V., Vandenabeele P., Agostinis P., Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulina. Cancer Immunology Immunotherapy 2012 61 2 215 221
211. Aymeric L., Apetoh L., Ghiringhelli F., Tesniere A., Martins I., Kroemer G., Smyth M. J., Zitvogel L., Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Research 2010 70 3 855 858 2-s2.0-76249128304 10.1158/0008-5472.CAN-09-3566